Multi-organ failure: innovative 4-in-1 therapy from ADVITOS receives funding
ADVITOS GmbH (“ADVITOS”), a Munich-based medical technology company, today announced the completion of a EUR 20 million…
ADVITOS GmbH (“ADVITOS”), a Munich-based medical technology company, today announced the completion of a EUR 20 million…
Das in München ansässige Medizintechnikunternehmen ADVITOS GmbH („ADVITOS“) gab heute den Abschluss einer Finanzierungs…